DSC_1321

Clinical and Post-Market

Demonstrate complete regulatory compliance by ensuring your in vitro diagnostic (IVD) device conforms to all applicable global requirements.

Delivering compliant IVD products to global markets

Choose Apotech for clinical compliance you can trust

Before placing an IVD device on the market, manufacturers must demonstrate compliance with all applicable global regulatory requirements  including In Vitro Diagnostic Regulation (IVDR), 21 CFR and the UK MDR 2002. 

At Apotech, our experienced team can make sure that you are conforming with the appropriate conformity assessment procedures. Working on your behalf, we can help you demonstrate that your IVD device achieves its intended purpose and corresponds to its claimed performance throughout its lifetime.

Smiling group of diverse businesspeople going over paperwork together and working on a laptop at a table in an office

Trusted by top-tier teams worldwide

Why choose Apotech for IVD clinical and post-market services?

Article 56 (1) of the IVDR states that IVD manufacturers must specify and justify the level of clinical evidence given a device’s characteristics and its intended purpose. Therefore, defining this intended purpose must be considered a key driver behind its overall assessment. 

Manufacturers must also ensure that they meet the essential requirements of the Medical Devices Regulations 2002 using data gathered through a performance evaluation. 

At Apotech, we can support you during the clinical stages of your IVD development in the following areas: 

  • Data establishment
  • Performance Evaluation Plan (PEP)
  • Performance Evaluation Report (PER)
  • Post-Market Performance Follow-Up (PMPF)
  • Validity
  • Analytical performance
  • Clinical performance

FAQs on IVD clinical and post-market services

At Apotech, we provide a tailored approach to our IVD clinical and post-market services. We aim to make the process as simple to understand as possible and are always on hand to answer any questions you might have. 

Here are some of the questions we get asked most often.

Featured case studies

GMP Audits

GMP Audits Introduction UK Based Biotech The company is a worldwide large biotech with a vast portfolio of biotech products (mainly oncology). Apotech auditors: 3 auditors are involved in this partnership. Types of Audits Contracts/agreements between the clients and the provider GMP/GDP Client SOPs Local regulations​ Audit Locations Europe   The audited sites are: Client manufacturing…

Read More

GMP QA Consulting​

GMP QA Consulting Introduction Global API Manufacturer The client was an API manufacturer, with a need for some support to cope with a deviation backlog. Apotech consultant: Two QA Consultants, with backgrounds in sterile devices. Types of Audits GMP  Tools: Ishikawa, 5M​ Audit Locations Europe Scope of work Under the QA director supervision, our consultant…

Read More

GxP Audits – Worldwide ​

GxP Audits – Worldwide Introduction Global Biopharmaceutical​ Our client is a global biotechnology company dedicated to novel treatments for patients through inhibition of protein kinases to fight cancer. They are Headquartered in the US, with a large footprint in the EU. Types of Audits GCP – For Cause / Investigator / Phase 1 unit​ GCLP – Central…

Read More

Ready to get started?